Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000569445

Apexbio Technology LLC DEFERASIROX-FE3-CHELATE-10MG
SDP

Catalog No. 5000569445
Encompass_Preferred

Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings

Catalog No. 50-005-69445 Supplier Apexbio Technology LLC Supplier No. A335510
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Deferasirox Fe3 chelate (CAS No 554435-83-5) is a critical compound in biomedical research primarily used in the study of iron overload disorders Originating from studies on iron chelation therapy its mechanism of action involves binding free iron ions to form a stable complex thereby preventing iron-mediated oxidative stress This chelation process targets pathways associated with iron homeostasis In vitro Deferasirox Fe3 chelate demonstrates activity in the nanomolar to low micromolar range indicating potent binding efficiency It is commonly applied in research using various cell models and animal studies to assess its efficacy and safety in chelation therapy contexts The compound is also utilized in drug screening efforts to develop treatments for conditions like thalassemia and sickle cell disease Experimental concentrations typically depend on the specific research design allowing flexibility in application across diverse experimental settings

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.